Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Furrer

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Schweizerische Medizinische Wochenschrift|March 17, 1979
[Clinical picture, diagnosis and therapy of renovascular hypertension]W Vetter, H Vetter, U Kuhlmann, et al.
HIV Medicine|May 8, 2019
Why do sub-Saharan Africans present late for HIV care in Switzerland?A Hachfeld, K Darling, A Calmy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2013
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy eraA Mocroft, H J Furrer, J M Miro, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Schweizerische Medizinische Wochenschrift|March 17, 1979
[Clinical picture, diagnosis and therapy of renovascular hypertension]W Vetter, H Vetter, U Kuhlmann, et al.
HIV Medicine|May 8, 2019
Why do sub-Saharan Africans present late for HIV care in Switzerland?A Hachfeld, K Darling, A Calmy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2013
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy eraA Mocroft, H J Furrer, J M Miro, et al.
Pageof 8